New Shigella Monoclonal Antibodies

Shigellosis is a foodborne gastrointestinal illness caused by several species of Shigella bacteria. Transmission is via the fecal-oral route and symptoms include cramps and diarrhea which can progress to dysentery. Shigella sonnei is the leading cause of disease in industrialized countries while Shigella flexneri is the most common species seen in developing countries; the predominate serotype being Shigella flexneri 2a.

ViroStat has recently released two sets of new Monoclonal Antibodies to Shigella: one set specific to Shigella sonnei and another set specific to Shigella flexneri 2a. Potential applications for these include direct bacterial detection by ELISA and lateral flow rapid tests.

About ViroStat
ViroStat was founded in 1985 by Douglas McAllister to provide infectious disease antibody tools to researchers and manufacturers. These include the areas of virology, bacteriology and parasitology. Applications for these include detection of respiratory agents, STD agents, gastrointestinal agents/toxins and food borne pathogens.

The company offers more than 500 infectious disease reagents including their MONOTOPE monoclonal antibodies, OMNITOPE polyclonal antibodies and numerous recombinant antigens. Many of these antibodies are used by manufacturers of rapid, point of care tests currently made and sold in the US.

Because ViroStat is the primary manufacturer of these antibodies, they have the knowledge and experience to offer excellent customer service and technical support to your laboratory staff on any scale from 100 ug to 10 grams.